The Supreme Court today will hear arguments in King v. Burwell, the highly anticipated case challenging the legality of subsidies available for individuals purchasing health insurance on the federal exchange under the Affordable Care Act.
With the health care reform law’s individual and employer mandates hanging in the balance, as well as the affordability of health insurance premiums, a ruling by the high court to invalidate the tax credits could have a lasting effect on many industry stakeholders, including:
